940 related articles for article (PubMed ID: 18051714)
21. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women.
Aromseree S; Wongjumpa W; Ekalaksananan T; Temtanakitpaisan A; Kleebkaow P; Srisathaporn S; Tongchai P; Pientong C
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3405-3411. PubMed ID: 36308365
[TBL] [Abstract][Full Text] [Related]
22. Reflex Human Papillomavirus Test Results as an Option for the Management of Korean Women With Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion.
Ryu KJ; Lee S; Min KJ; Kim JW; Hong JH; Song JY; Lee JK; Lee NW
Oncologist; 2015 Jun; 20(6):635-9. PubMed ID: 25964305
[TBL] [Abstract][Full Text] [Related]
23. Repeat cytology and human papillomavirus screening strategies in detecting preinvasive cervical lesions.
Li K; Yin R
Medicine (Baltimore); 2015 Feb; 94(5):e435. PubMed ID: 25654377
[TBL] [Abstract][Full Text] [Related]
24. Pooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopy.
Hu SY; Zhang WH; Li SM; Li N; Huang MN; Pan QJ; Zhang X; Han Y; Zhao FH; Chen W; Qiao YL
Medicine (Baltimore); 2017 Apr; 96(17):e6689. PubMed ID: 28445270
[TBL] [Abstract][Full Text] [Related]
25. The Impact of Triage for Atypical Squamous Cells of Undetermined Significance with Human Papillomavirus Testing in Cervical Cancer Screening in Japan.
Fujiwara H; Suzuki M; Morisawa H; Sayama M; Kimura K
Asian Pac J Cancer Prev; 2019 Jan; 20(1):81-85. PubMed ID: 30678384
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Aptima and hybrid capture-2 HPV tests and Pap test in the referral population in Japan.
Kuroki H; Sakamoto J; Shibata T; Takakura M; Sasagawa T
J Med Virol; 2021 Aug; 93(8):5076-5083. PubMed ID: 33634473
[TBL] [Abstract][Full Text] [Related]
27. Atypical squamous cells of undetermined significance-favour reactive compared to atypical squamous cells of undetermined significance-favour dysplasia: association with cervical intraepithelial lesions and human papillomavirus infection.
Giovannelli L; Capra G; Lama A; Bustinto T; Genco A; Valenti FM; Pinto G; Matranga D; Ammatuna P
J Clin Virol; 2005 Aug; 33(4):281-6. PubMed ID: 16036177
[TBL] [Abstract][Full Text] [Related]
28. Should LSIL-H be a distinct cytology category?: A study on the frequency and distribution of 40 human papillomavirus genotypes in 808 women.
Zhou H; Schwartz MR; Coffey D; Smith D; Mody DR; Ge Y
Cancer Cytopathol; 2012 Dec; 120(6):373-9. PubMed ID: 22648956
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia.
Holladay EB; Logan S; Arnold J; Knesel B; Smith GD
Cancer; 2006 Dec; 108(6):451-61. PubMed ID: 17078096
[TBL] [Abstract][Full Text] [Related]
30. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
Duby JM; DiFurio MJ
Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
[TBL] [Abstract][Full Text] [Related]
31. The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy.
Arbyn M; Roelens J; Cuschieri K; Cuzick J; Szarewski A; Ratnam S; Reuschenbach M; Belinson S; Belinson JL; Monsonego J
Int J Cancer; 2013 Jan; 132(1):101-8. PubMed ID: 22610699
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
[TBL] [Abstract][Full Text] [Related]
33. Low-grade squamous intraepithelial lesion, cannot rule out high-grade lesion: Diagnosis, histological outcomes and human papillomavirus results.
Segura SE; Ramos-Rivera G; Hakima L; Suhrland M; Khader S
Cytopathology; 2019 Jan; 30(1):99-104. PubMed ID: 30187975
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of gene chip technology for high risk type human papillomavirus in cervical cancer screening].
Li RZ; Shi JF; Zhou QZ; Wu RF; Li N; Wu LN; Zhou YQ; Wang Q; Liu ZH; Liu B; Qiao YL
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(5):307-11. PubMed ID: 16677522
[TBL] [Abstract][Full Text] [Related]
35. [Relationship between cervical lesions and the type-specific viral load of high risk HPV reflected by the Ct value of Cobas 4800 HPV system].
Duan LF; Du H; Xiao AM; Wang C; Huang X; Zhao MF; Men HJ; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2019 Jul; 54(7):458-463. PubMed ID: 31365958
[No Abstract] [Full Text] [Related]
36. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S
BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073
[TBL] [Abstract][Full Text] [Related]
37. [Triage value of high risk human papilloma virus detection in women with abnormal cervical cytology].
Jin Y; Pan LY; Wang YF; Cheng XM; Lang JH
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1173-6. PubMed ID: 18844110
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus testing with a liquid-based system: feasibility and comparison with reference diagnoses.
Bergeron C; Cas F; Fagnani F; Didailler-Lambert F; Poveda JD
Acta Cytol; 2006; 50(1):16-22. PubMed ID: 16514835
[TBL] [Abstract][Full Text] [Related]
40. Cervical Cancer Screening: A Review.
Perkins RB; Wentzensen N; Guido RS; Schiffman M
JAMA; 2023 Aug; 330(6):547-558. PubMed ID: 37552298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
